Patents for Toll-like receptor ligands as radiation countermeasures for acute radiation syndrome
about
Medical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patentsRadioprotective Agents: Strategies and Translational Advances.Recent progress in the development of Toll-like receptor (TLR) antagonists.Mannan oligosaccharide requires functional ETC and TLR for biological radiation protection to normal cells.
P2860
Patents for Toll-like receptor ligands as radiation countermeasures for acute radiation syndrome
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Patents for Toll-like receptor ...... s for acute radiation syndrome
@ast
Patents for Toll-like receptor ...... s for acute radiation syndrome
@en
type
label
Patents for Toll-like receptor ...... s for acute radiation syndrome
@ast
Patents for Toll-like receptor ...... s for acute radiation syndrome
@en
prefLabel
Patents for Toll-like receptor ...... s for acute radiation syndrome
@ast
Patents for Toll-like receptor ...... s for acute radiation syndrome
@en
P2860
P1476
Patents for Toll-like receptor ...... s for acute radiation syndrome
@en
P2093
Harvey B Pollard
P2860
P304
P356
10.1517/13543776.2015.1064900
P407
P577
2015-07-01T00:00:00Z